{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:43:12Z","timestamp":1784335392917,"version":"3.55.0"},"reference-count":121,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Annals of Neurology"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>We review the positive effects of several existing drugs from different classes, such as chemical chaperones, glucagon\u2010like peptide\u20101 receptor agonists (GLP\u20101 RAs), iron chelators, and cluster\u2010Abelson tyrosine kinase inhibitors (c\u2010Abl TKIs), in preclinical disease models and in available published human data following use of these drugs in individuals with common neurodegenerative diseases (NDs), including Parkinson's disease (PD), Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). A concept of combinatory neuroprotective therapy using a drug\u2010repurposing approach is then discussed. Finally, we propose a strategy to design an ideal combination of drugs able to address multiple pathogenic processes involved in neurodegeneration to achieve clinically meaningful results. ANN NEUROL 2026 ANN NEUROL 2026;99:1099\u20131112<\/jats:p>","DOI":"10.1002\/ana.78190","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:46:39Z","timestamp":1775126799000},"page":"1099-1112","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination Disease\u2010Modifying Therapy for Neurodegenerative Diseases Using Repurposed Drugs"],"prefix":"10.1002","volume":"99","author":[{"given":"Alexander","family":"Shtilbans","sequence":"first","affiliation":[{"name":"Department of Neurology Hospital for Special Surgery  New York NY"},{"name":"Department of Neurology Weill Cornell Medicine  New York NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[{"name":"Edmond J. Safra Program in Parkinson's Disease and the Rossy PSP Centre, Toronto Western Hospital University of Toronto  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028035"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-308350"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2017.147"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.28"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2016.04.010"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2490"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00020"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.07-099671"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-017-0077-5"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/ac400023c"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033371"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2015.09.012"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0228-x"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1492028"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2021.12.004"},{"key":"e_1_2_13_17_1","article-title":"Evaluation of additive neuroprotective effect of combination therapy for Parkinson's disease using in vitro models","volume":"14","author":"Shtilbans A","year":"2025","journal-title":"Antioxidants (Basel)."},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215680"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026622666220907114443"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2019.10.001"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.229"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009135"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww137"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038113"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2009.03.002"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.211029"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/17482960802226148"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/17482960802320487"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916945"},{"key":"e_1_2_13_30_1","first-page":"2294","article-title":"Sodium Phenylbutyrate\u2010Taurursodiol for ALS","volume":"383","author":"Paganoni S","year":"2020","journal-title":"Reply. N Engl J Med."},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410210200"},{"key":"e_1_2_13_32_1","unstructured":"CohenJB KleeJ.Inventors compositions for improving cell viability and methods of use there of patent WO 2014\/158547 A1 2014."},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.09.003"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-012-8256-y"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121471"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.2119\/2003-00042.Rodrigues"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.3727\/096020198389960"},{"key":"e_1_2_13_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-006-9053-9"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-012-8295-4"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2017.06.004"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12664"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.2001.7755"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.162362299"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.2174\/1567205016666190913155950"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-09-0132"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312323"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114187"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032008"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0799"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1234958"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0361282"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00972-w"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2013.5593"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209254"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.906618"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4617"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2018.04.002"},{"key":"e_1_2_13_58_1","unstructured":"MOUSSA C.Inventor treating neural disease with tyrosine kinase inhibitors patent WO2013\/166295 A1 2013."},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2015.07.070"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2021.102031"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25775"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28858"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.4200"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230319"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt192"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28389"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.4725"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046185"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00203"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddr477"},{"key":"e_1_2_13_71_1","unstructured":"TruogP.Inventor4\u2010phenylbutyric acid controlled\u2010release formulations for therapeutic use patent US 2006\/0045912 A1."},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.4161\/pri.28938"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.7453\/gahmj.2014.017"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119252"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-018-0235-9"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01165-15"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.29450"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26999"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28449-z"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181503"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134221"},{"key":"e_1_2_13_82_1","first-page":"1693","article-title":"Cardioprotection by exenatide: a novel mechanism via improving mitochondrial function involving the GLP\u20101 receptor\/cAMP\/PKA pathway","volume":"41","author":"Chang G","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"e_1_2_13_83_1","unstructured":"Oramed Ltd assignee.Methods and compositions for oral administration of exenatide patent US10350162B2."},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2012.04.009"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31585-4"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)02808-3"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.1177\/17562864251372747"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.107132"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.10.017"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-130230"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.202928"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-08048-y"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228765"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.1134\/S0006350915060081"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-018-1333-0"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40250-0"},{"key":"e_1_2_13_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.01.006"},{"key":"e_1_2_13_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0531-5565(00)00253-9"},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105649"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56110626"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.22336\/rjo.2021.23"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2013.00167"},{"key":"e_1_2_13_103_1","first-page":"239","article-title":"A review on iron chelators in treatment of iron overload syndromes","volume":"10","author":"Mobarra N","year":"2016","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.09.121"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/983245"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep04874"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp9352"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab271"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102651"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30038-8"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00497-6"},{"key":"e_1_2_13_112_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49016-3"},{"key":"e_1_2_13_113_1","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2595"},{"key":"e_1_2_13_114_1","doi-asserted-by":"publisher","DOI":"10.1177\/17407745241240401"},{"key":"e_1_2_13_115_1","doi-asserted-by":"publisher","DOI":"10.1177\/09622802211052746"},{"key":"e_1_2_13_116_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9402"},{"key":"e_1_2_13_117_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07703-6"},{"key":"e_1_2_13_118_1","doi-asserted-by":"publisher","DOI":"10.1002\/pst.1497"},{"key":"e_1_2_13_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2013.07.002"},{"key":"e_1_2_13_120_1","doi-asserted-by":"publisher","DOI":"10.1080\/10543406.2020.1815033"},{"key":"e_1_2_13_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2022.100901"},{"key":"e_1_2_13_122_1","first-page":"336","article-title":"Sequential, multiple assignment","volume":"329","author":"Kidwell KM","year":"2023","journal-title":"Randomized Trial Designs. JAMA."}],"container-title":["Annals of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.78190","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ana.78190","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ana.78190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:48:30Z","timestamp":1777092510000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ana.78190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1002\/ana.78190"],"URL":"https:\/\/doi.org\/10.1002\/ana.78190","archive":["Portico"],"relation":{},"ISSN":["0364-5134","1531-8249"],"issn-type":[{"value":"0364-5134","type":"print"},{"value":"1531-8249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"2025-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}